source
- MDCalc introduces quality-rating system for over 800 clinical calculators used by doctorsMDCalc, a health‑technology company, announced a new quality‑rating system that will evaluate the more than 800 clinical calculators doctors rely on for decisions such as kidney function, birth out…
- GSK halts camlipixant development after mixed Phase 3 results curb blockbuster hopesGSK announced it is stopping work on camlipixant, a P2X3 receptor antagonist it bought when acquiring Bellus Health in 2023, after the drug produced mixed results in two Phase 3 chronic cough trial…